Ethics, Justice and Community Participation in the Microbicides Development Programme (MDP) Phase III Trial in Mwanza, Tanzania

American Journal of Bioethics

Volumn 12, Issue 11, 2012, Pages 46-48

  Vallely, Andrew ^a,b   Lees, Shelley ^a,b   Shagi, Charles ^c   Kapiga, Saidi ^a,b   McCormack, Sheena ^d   Hayes, Richard ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c African Medical and Research Foundation   (South Africa)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); DEVELOPED COUNTRY; DEVELOPING COUNTRY; ETHICAL THEORY; ETHICS; HEALTH CARE DISPARITY; HEALTH STATUS; HUMAN; MORALITY; PERSONNEL; SOCIAL JUSTICE;

CLINICAL TRIALS AS TOPIC; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; ETHICAL THEORY; HEALTH STATUS; HEALTHCARE DISPARITIES; HUMANS; MORAL OBLIGATIONS; RESEARCH PERSONNEL; SOCIAL JUSTICE;

EID: 84867621198     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2012.719268     Document Type: Article

References (14)

1. Allen, C. F., Lees, S. S.Desmond, N. A. 2007. Validity of coital diaries in a feasibility study for the Microbicides Development Programme trial among women at high risk of HIV/AIDS in Mwanza, Tanzania. Sexually Transmitted Infections, 83(6): 490-496. discussion 496-497
2. Heise, L., Shapiro, K. and West Slavin, K. 2008. Mapping the standards of care at microbicide clinical trial sites, Washington, DC: Global Campaign for Microbicides.
3. Lees, S., Desmond, N., Allen, C., Bugeke, G. and Vallely, A. 2009. Sexual risk behaviour for women working in recreational venues in Mwanza, Tanzania: Considerations for the acceptability and use of vaginal microbicide gels. Culture, Health & Sexuality, 11(6): 581-595.
4. McCormack, S., Ramjee, G.Kamali, A. 2010. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): A phase 3, randomised, double-blind, parallel-group trial. Lancet, 376(9749): 1329-1337.
5. Montgomery, C. M., Lees, S.Stadler, J. 2008. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care, 20(6): 733-740.
6. Nunn, A., McCormack, S., Crook, A. M., Pool, R., Rutterford, C. and Hayes, R. 2009. Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials, 10: 99
7. Pool, R., Montgomery, C. M.Morar, N. S. 2010. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS ONE, 5(7): e11600
8. Pratt, B., Zion, D. and Loff, B. 2012. Evaluating the capacity of theories of justice to serve as a justice framework for international clinical research. American Journal of Bioethics, 12(11): 30-41.
9. Shagi, C., Vallely, A.Kasindi, S. 2008. A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa. AIDS Care, 20(9): 1039-1049.
10. UNAIDS. 2004. Women and HIV/AIDS: Confronting the crisis, Geneva, Switzerland: UNAIDS, UNFPA, and UNIFEM.
11. Vallely, A., Lees, S.Shagi, C. 2010. How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania. BMC Medical Ethics, 11: 10
12. Vallely, A., Shagi, C.Kasindi, S. 2007. The benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania. BMC Public Health, 7: 133
13. Vallely, A., Shagi, C.Lees, S. 2009. Microbicides Development Programme: Engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania. BMC Medical Ethics, 10: 17
14. Wilson, D. P. and Coplan, P. M. 2008. Mathematical models and health economic aspects of microbicides. Current Opinions in HIV and AIDS, 3: 587-592.